
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI
[ Fri, Nov 30th 2018 ]: WOPRAI

[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI
[ Thu, Nov 29th 2018 ]: WOPRAI

[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI
[ Wed, Nov 28th 2018 ]: WOPRAI

[ Tue, Nov 27th 2018 ]: WOPRAI
[ Tue, Nov 27th 2018 ]: WOPRAI

[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI
[ Mon, Nov 26th 2018 ]: WOPRAI

[ Fri, Nov 23rd 2018 ]: WOPRAI
[ Fri, Nov 23rd 2018 ]: WOPRAI
[ Fri, Nov 23rd 2018 ]: WOPRAI
[ Fri, Nov 23rd 2018 ]: WOPRAI
[ Fri, Nov 23rd 2018 ]: WOPRAI

[ Wed, Nov 21st 2018 ]: WOPRAI
[ Wed, Nov 21st 2018 ]: WOPRAI
[ Wed, Nov 21st 2018 ]: WOPRAI
[ Wed, Nov 21st 2018 ]: WOPRAI
[ Wed, Nov 21st 2018 ]: WOPRAI
[ Wed, Nov 21st 2018 ]: WOPRAI
[ Wed, Nov 21st 2018 ]: WOPRAI

[ Tue, Nov 20th 2018 ]: WOPRAI
[ Tue, Nov 20th 2018 ]: WOPRAI
Paul Matteis Initiated (ALNY) at Hold and Held Target at $63 on, Nov 28th, 2018


🞛 This publication is a summary or evaluation of another publication
Paul Matteis of Leerink Swann, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $63 on, Nov 28th, 2018.
Paul has made no other calls on ALNY in the last 4 months.
There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $87 on, Friday, September 28th, 2018
These are the ratings of the 6 analyists that currently disagree with Paul
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $124 on, Tuesday, October 16th, 2018
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $135 on, Monday, October 1st, 2018
- Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018
- Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018
- Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
- Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018
Similar Stocks and Investing Publications
[ Tue, Oct 16th 2018 ]: WOPRAI
[ Mon, Oct 01st 2018 ]: WOPRAI
[ Fri, Sep 28th 2018 ]: WOPRAI
[ Thu, Sep 13th 2018 ]: WOPRAI
[ Thu, Jan 25th 2018 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Thu, Nov 09th 2017 ]: WOPRAI
[ Wed, Nov 08th 2017 ]: WOPRAI
[ Wed, Nov 08th 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Thu, Nov 02nd 2017 ]: WOPRAI
[ Mon, Oct 30th 2017 ]: WOPRAI